Latest News

Personalizing Colon Cancer Treatment
Tumor suppressing molecule that prevents growth could lead to personalized therapy.
Treatment could make existing cancer drugs more effective.
Drug decreases enthesitis and dactylitis by blocking the production of cytokines that promote inflammation.
Hydrogel prevents drugs from prematurely leaving the body.
Top stories of the week on Specialty Pharmacy Times from June 29 through July 3.
Company allegedly continued to make and ship unapproved products after multiple warnings.
Lung function and health status decreases across all levels of severity.
The impact of products such as orange juice on melanoma.


Recently published data from a survey of commercial health plans reveal the latest trends and emerging strategies in oncology management.
Anticipated near-term specialty drug approvals include new therapies for cancer, orphan conditions, high cholesterol, and asthma.
Mobile adherence apps are a great boon to patients who face the responsibility of taking oral chemotherapy drugs as directed without in-person supervision by clinicians.
Pharmaceutical companies and clinical oncology teams are collaborating to harness large sets of patient data, paving the way for more informed and individualized decision-making about treatments.
As oncology spending rises, insurers and manufacturers are looking to specialty pharmacy programs to maximize the effectiveness of cancer therapies.
There are several key factors a specialty pharmacy must consider when deciding whether to participate in a limited distribution network.


CEO of Avella Specialty Pharmacy Rebecca M. Shanahan, Esq., discusses how specialty pharmacies can best manage the rising cost of specialty drugs to improve outcomes for patients.

Michael Zeglinski, Vice President of Specialty Pharmacy Operations at BriovaRx, discusses developing trends in the treatment of specialty pharmacy patients.

Amy Grogg, PharmD, senior vice president of Strategy and Commercialization at AmerisourceBergen Specialty Group discusses how the Affordable Care Act has emphasized the importance of specialty pharmacy services.

Ron Lanton III, Esq, president of True North Political Solutions, LLC, discusses how the specialty pharmacy landscape will evolve in the coming years.

Company Profile >
Contributor >
Industry Guide >
Market News >
Peer Exchange >
Subscribe >
Specialty Times Resources
About Us
Contact Us
Terms & Conditions
MJH Associates >
Pharmacy Times
American Journal of Managed Care
Targeted Oncology
Physicians' Education Resource
Intellisphere, LLC
666 Plainsboro Road
Building 300
Plainsboro, NJ 08536
P: 609-716-7777
F: 609-716-4747

Copyright Specialty Pharmacy Times 2006-2015
Intellisphere, LLC. All Rights Reserved.